iTolerance (Seed+)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$10,000,000

Company Info
Founders
Anthony Japour
Company Description
Pioneering regenerative medicine without immunosuppression iTolerance is a biotechnology company focused on regenerative medicine without immunosuppression.
Market
Healthcare & Wellness

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement